The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for General Cardiac Technology sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
General Cardiac Technology Inc (General Cardiac) is a medical device company that provides post surgical products. The company manufactures support harness for cardiovascular bypass surgery patient to control the wound stress. It also offers products such as heart hugger, surgi support vest, and others. General Cardiac provides products used in treatment for sternotomy and thoracotomy patients by returning to pre-op respiratory levels and stabilizing their sternal or thoracic wound. The company offers services such as nursing service and patient education. It markets its products in the US and abroad. General Cardiac is headquartered in San Jose, California, the US.
The key metrics of General Cardiac Technology related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As General Cardiac Technology is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as General Cardiac Technology.
For a detailed understanding of the performance of General Cardiac Technology, buy the report here.